Clinical Trial Update: PRevention Using EPA Against coloREctal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/Phase 2 trial evaluating eicosapentaenoic acid (EPA) for prevention of colorectal cancer and colorectal adenoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Adenoma
• Colorectal Cancer

Drugs mentioned

• Eicosapentaenoic acid (eicosapentaenoic acid)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Colorectal Adenoma, Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2024-02-14